The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2020

Filed:

Dec. 18, 2015
Applicant:

Eth Zurich, Zurich, CH;

Inventors:

Jan Kisielow, Schlieren, CH;

Franz-Josef Obermair, Oberengstringen, CH;

Manfred Kopf, Zurich, CH;

Assignee:

ETH Zurich, Zurich, CH;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/74 (2006.01); C12N 15/10 (2006.01); A61K 35/17 (2015.01); C07K 14/725 (2006.01); C12N 5/0783 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1055 (2013.01); A61K 35/17 (2013.01); C07K 14/7051 (2013.01); C07K 14/70539 (2013.01); C12N 5/0636 (2013.01); G01N 33/505 (2013.01); C07K 2319/03 (2013.01); C07K 2319/40 (2013.01); C07K 2319/60 (2013.01); C07K 2319/61 (2013.01);
Abstract

The invention relates to a chimeric antigen-receptor polypeptide heterodimer comprising two polypeptides, wherein the first contains an extracellular part of the major histocompatibility complex I alpha chain and the second contains a 32-microglobulin domain, or the first contains an extracellular part of the major histocompatibility complex II alpha chain and the second contains a major histocompatibility complex II beta chain. One of the polypeptides further contains a transmembrane domain, a hinge region and an intracellular domain of the T cell receptor alpha chain and the other one contains a transmembrane domain, a hinge region and an intracellular domain of the T cell receptor beta chain, and additionally an antigen-peptide covalently linked to said extracellular MHC domain. The invention further relates to a method for the identification of a TCR recognizable peptide sequence making use of the heterodimer of the invention.


Find Patent Forward Citations

Loading…